159 related articles for article (PubMed ID: 34415785)
1. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
Lee YS; Choi MH; Lee YJ; Han D; Kim DH
Br J Radiol; 2022 Mar; 95(1131):20210479. PubMed ID: 34415785
[TBL] [Abstract][Full Text] [Related]
2. 3D MR fingerprinting (MRF) for simultaneous T1 and T2 quantification of the bone metastasis: Initial validation in prostate cancer patients.
Choi MH; Lee SW; Kim HG; Kim JY; Oh SW; Han D; Kim DH
Eur J Radiol; 2021 Nov; 144():109990. PubMed ID: 34638082
[TBL] [Abstract][Full Text] [Related]
3. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Shiradkar R; Panda A; Leo P; Janowczyk A; Farre X; Janaki N; Li L; Pahwa S; Mahran A; Buzzy C; Fu P; Elliott R; MacLennan G; Ponsky L; Gulani V; Madabhushi A
Eur Radiol; 2021 Mar; 31(3):1336-1346. PubMed ID: 32876839
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters.
Choi MH; Lee YJ; Han D; Kim DH
Curr Oncol; 2023 Dec; 30(12):10299-10310. PubMed ID: 38132384
[TBL] [Abstract][Full Text] [Related]
5. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
[TBL] [Abstract][Full Text] [Related]
6. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
7. Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.
Latifoltojar A; Dikaios N; Ridout A; Moore C; Illing R; Kirkham A; Taylor S; Halligan S; Atkinson D; Allen C; Emberton M; Punwani S
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):343-51. PubMed ID: 26195470
[TBL] [Abstract][Full Text] [Related]
8. Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Chen C; Yang Z; Sweeney E; Hectors SJ; Hu JC; Margolis DJ
Abdom Radiol (NY); 2021 Nov; 46(11):5369-5376. PubMed ID: 34292363
[TBL] [Abstract][Full Text] [Related]
9. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach.
Maas MC; Litjens GJS; Wright AJ; Attenberger UI; Haider MA; Helbich TH; Kiefer B; Macura KJ; Margolis DJA; Padhani AR; Selnæs KM; Villeirs GM; Fütterer JJ; Scheenen TWJ
Invest Radiol; 2019 Jul; 54(7):437-447. PubMed ID: 30946180
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
de Oliveira Correia ET; Qiao PL; Griswold MA; Chen Y; Bittencourt LK
Eur J Radiol; 2023 Jul; 164():110883. PubMed ID: 37209463
[TBL] [Abstract][Full Text] [Related]
11. MR fingerprinting of the prostate.
Lo WC; Panda A; Jiang Y; Ahad J; Gulani V; Seiberlich N
MAGMA; 2022 Aug; 35(4):557-571. PubMed ID: 35419668
[TBL] [Abstract][Full Text] [Related]
12. Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer.
Rudolph MM; Baur ADJ; Haas M; Cash H; Miller K; Mahjoub S; Hartenstein A; Kaufmann D; Rotzinger R; Lee CH; Asbach P; Hamm B; Penzkofer T
Eur Radiol; 2020 Aug; 30(8):4262-4271. PubMed ID: 32219507
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies.
Han D; Choi MH; Lee YJ; Kim DH
Korean J Radiol; 2021 Aug; 22(8):1332-1340. PubMed ID: 34047506
[TBL] [Abstract][Full Text] [Related]
14. Value of T
Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
[TBL] [Abstract][Full Text] [Related]
16. The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T
Sushentsev N; Kaggie JD; Buonincontri G; Schulte RF; Graves MJ; Gnanapragasam VJ; Barrett T
Sci Rep; 2020 Nov; 10(1):20475. PubMed ID: 33235229
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
18. Zone-specific logistic regression models improve classification of prostate cancer on multi-parametric MRI.
Dikaios N; Alkalbani J; Abd-Alazeez M; Sidhu HS; Kirkham A; Ahmed HU; Emberton M; Freeman A; Halligan S; Taylor S; Atkinson D; Punwani S
Eur Radiol; 2015 Sep; 25(9):2727-37. PubMed ID: 25680730
[TBL] [Abstract][Full Text] [Related]
19. The role of gadolinium in magnetic resonance imaging for early prostate cancer diagnosis: A diagnostic accuracy study.
Cosma I; Tennstedt-Schenk C; Winzler S; Psychogios MN; Pfeil A; Teichgraeber U; Malich A; Papageorgiou I
PLoS One; 2019; 14(12):e0227031. PubMed ID: 31869380
[TBL] [Abstract][Full Text] [Related]
20. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
